Financials

  • Market Capitalization 32.1892 M
  • Employee 4
  • Founded 2006
  • CEO N/A
  • Website www.briacell.com
  • Headquarter British Columbia, Canada
  • FIGI BBG0018783B6
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
0.44
Price to sales ratio
-9.75

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
7416
ESLAW
Estrella Immunopharma, Inc. - Warrant
0.1000 USD0.00%-26.58%-23.08%+183.29%35.29 M USD
7418
APLMW
Apollomics Inc. - Warrant
0.0117 USD+1.74%-4.10%0.00%-55.34%34.48 M USD
7423
BCTXZ
BriaCell Therapeutics Corp. - Warrant
0.0999 USD-0.10%-0.10%+25.66%-69.73%32.19 M USD
7436
NRSNW
NeuroSense Therapeutics Ltd. - Warrant
0.1275 USD0.00%-7.61%+6.25%-77.21%23.77 M USD

Frequently asked questions about BriaCell Therapeutics Corp. - Warrants

What is the BriaCell Therapeutics Corp. - Warrants stock price today?

The current price of BriaCell Therapeutics Corp. - Warrants (BCTXL) is 0.93. Over the past 24 hours, the stock has changed by +8.14%. Follow the BCTXL chart for real-time price dynamics.

What is the stock ticker of BriaCell Therapeutics Corp. - Warrants?

BriaCell Therapeutics Corp. - Warrants trades under the ticker BCTXL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is BriaCell Therapeutics Corp. - Warrants stock going up?

BCTXL has changed by +5.68% over the last week, +39.85% over the last month, and +43.08% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was BriaCell Therapeutics Corp. - Warrants net income for the last quarter?

BriaCell Therapeutics Corp. - Warrants reported net income of -7.16 M for the last quarter. The previous quarter showed -7.22 M, which means net income changed by +0.79%.

How many employees does BriaCell Therapeutics Corp. - Warrants have?

As of the latest available data, BriaCell Therapeutics Corp. - Warrants has 4 employees. Workforce size can provide additional context about the company's scale and operations.

What is BriaCell Therapeutics Corp. - Warrants EBITDA?

BriaCell Therapeutics Corp. - Warrants EBITDA is -7.59 M, and its EBITDA margin is 289.82 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy BriaCell Therapeutics Corp. - Warrants stock?

You can buy BriaCell Therapeutics Corp. - Warrants (BCTXL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in BriaCell Therapeutics Corp. - Warrants stock?

Investing in BriaCell Therapeutics Corp. - Warrants requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCTXL chart and related analysis on metatrader.com as part of your research.